PSEN1 and Alzheimer disease: Although no model of AD fully recapitulates the human disease [44], APP.PS1 mice are well suited for our studies because they exhibit: 1) high production of Aβ peptides in brain and accumulation of amyloid plaques by 4–6 months of age [45], and 2) cholinergic defects [46–50].